Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization-Reference-Cited by-同舟云学术

Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization

Published:2023-01 Issue: Volume:245 Page:114916
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Girardini Miriam,Ferlenghi Francesca,Annunziato Giannamaria,Degiacomi Giulia,Papotti Bianca,Marchi Cinzia,Sammartino José Camilla,Rasheed Sari S.,Contini Anna,Pasca Maria Rosalia,Vacondio Federica,Evans Joanna C.,Dick Thomas,Müller Rolf,Costantino Gabriele,Pieroni Marco^ORCID

Funder

National Institute of Allergy and Infectious Diseases

Ministero dell’Istruzione, dell’Università e della Ricerca

National Institutes of Health

Università degli Studi di Pavia

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference69 articles.

1. Mycobacterium tuberculosis: an adaptable pathogen associated with multiple human diseases;Chai;Front. Cell. Infect. Microbiol.,2018

2. Differential identification of mycobacterial species using high-resolution melting analysis;Khosravi;Front. Microbiol.,2017